Furthermore, the analysis of immunotherapy-predicted pathways signified that risk score was correlated with the classical pathways including FGFR3-coexpressed genes, viral carcinogenesis, pyrimidine metabolism, p53 signaling pathway, microRNAs in cancer, APM signal, and IFN-γ signature (Fig. 4A,B, Tables S7, 8). The gene discussed is TP53; the disease is cancer.